Landos Biopharma Inc (LABP)

$0.00 $0.00 (0.00%) 4:38 PM 12/11/24
NASDAQ | $USD | Biotechnology

Stock Data

  • Market Cap

    $71.68M

  • Day's Range

    - - -

  • Volume

    -

  • 52 Week Low / High

    $3.21 - $22.94

  • PE Ratio

    -

  • PEG Ratio

    -

  • Dividend Frequency

    -

LABP's Dividend
-
Amount
-
Dividend Yield
-
Payment Date
-
Annual Dividend Amount
Dividend Streak
Hypothetical 10k Investment Jan 1, 2020
Capital Growth
Dividend Return to Date
Dividend Payout year Est.
Expenses
Total Return
Total Return %
Analyists Ranking
0
Strong Buy
0
Buy
2
Hold
0
Sell
0
Strong Sell
$5.00
Target Price

Company News

  • AbbVie Completes Acquisition of Landos Biopharma — May 23rd, 2024

    -   Adds first-in-class investigational asset, NX-13, to AbbVie's pipeline with the potential to offer a novel approach to the treatment of ulcerative colitis (UC) and Crohn's disease (CD) NORTH CHICAGO, Ill., May 23, 2024 /PRNewswire/ -- AbbVie (NYSE: ABBV) announced today that it has ...

Similar Stocks

No similar stocks found.

Want to be notified on dividend changes?

Start manging your portfolio today.

Sign up for free